Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Avalon GloboCare Corp.

Get SEC filing alerts via email and in your feed for Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

About Avalon GloboCare Corp.

Avalon GloboCare Corp. develops and markets precision diagnostic consumer products, primarily the KetoAir breathalyzer, which measures ketosis levels to support diabetic and ketogenic diet management. The company previously offered laboratory testing services but has since exited that segment. It operates mainly in the U.S. market, leveraging FDA-cleared medical device technology combined with AI-driven nutrition software, targeting health-conscious consumers through direct online sales and digital marketing channels.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Avalon GloboCare Corp.

1
1
Avalon GloboCare Corp. Avalon GloboCare Reports $4.48 Million Net Loss and Strategic Shift Towards KetoAir Device

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
Avalon GloboCare Corp. Avalon GloboCare Reports $18.3 Million Net Loss and Strategic Shift to AI Technology

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Avalon GloboCare Corp. Avalon GloboCare Reports Q3 2025 Financial Results with Decreased Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Avalon GloboCare Corp. Avalon GloboCare Reports $13.5 Million Net Loss and Decreased Assets in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Avalon GloboCare Corp. Avalon GloboCare Reports $2.48 Million Net Loss and Increased Revenue Amid Operational Changes

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Avalon GloboCare Corp. Avalon GloboCare Reports 52.7% Reduction in Net Losses for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Avalon GloboCare Corp. Avalon GloboCare Reports Revenue Growth, Improved Cash Position, and Ongoing Challenges in Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments